Literature DB >> 30790272

Clinical delineation of GTPBP2-associated neuro-ectodermal syndrome: Report of two new families and review of the literature.

Melissa T Carter1, Sunita Venkateswaran2, Gali Shapira-Zaltsberg3, Jorge Davila3, Peter Humphreys2, Kristin D Kernohan4, Kym M Boycott1,4.   

Abstract

The GTPBP2 gene encodes a guanosine triphosphate (GTP)-binding protein of unknown function. Biallelic loss-of-function variants in the GTPBP2 gene have been previously reported in association with a neuro-ectodermal clinical presentation in six individuals from four unrelated families. Here, we provide detailed descriptions of three additional individuals from two unrelated families in the context of the previous literature. Both families carry nonsense variants in GTPBP2: homozygous p.(Arg470*) and compound heterozygous p.(Arg432*)/p.(Arg131*). Key features of this clinically recognizable condition include prenatal onset microcephaly, tone abnormalities, and movement disorders, epilepsy, dysmorphic features, retinal dysfunction, ectodermal dysplasia, and brain iron accumulation. Our findings suggest that some aspects of the clinical presentation appear to be age-related; brain iron accumulation may appear only after childhood, and the ectodermal findings and peripheral neuropathy are most prominent in older individuals. In addition, we present prenatal and neonatal findings as well as the first Caucasian and black African families with GTPBP2 biallelic variants. The individuals described herein provide valuable additional phenotypic information about this rare, novel, and progressive neuroectodermal condition.
© 2019 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  GTPBP2; ectodermal dysplasia; epilepsy; iron; microcephaly; substantia nigra

Mesh:

Substances:

Year:  2019        PMID: 30790272     DOI: 10.1111/cge.13523

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  5 in total

Review 1.  Cerebral Iron Deposition in Neurodegeneration.

Authors:  Petr Dusek; Tim Hofer; Jan Alexander; Per M Roos; Jan O Aaseth
Journal:  Biomolecules       Date:  2022-05-17

2.  GTPBP1 resolves paused ribosomes to maintain neuronal homeostasis.

Authors:  Markus Terrey; Scott I Adamson; Alana L Gibson; Tianda Deng; Ryuta Ishimura; Jeffrey H Chuang; Susan L Ackerman
Journal:  Elife       Date:  2020-11-13       Impact factor: 8.140

Review 3.  The trinity of ribosome-associated quality control and stress signaling for proteostasis and neuronal physiology.

Authors:  Jumin Park; Jongmin Park; Jongbin Lee; Chunghun Lim
Journal:  BMB Rep       Date:  2021-09       Impact factor: 4.778

4.  GTPBP2 positively regulates the invasion, migration and proliferation of non-small cell lung cancer.

Authors:  Liu Jie; Li Cong; Wei Conghui; Gao Ying
Journal:  J Cancer       Date:  2021-05-05       Impact factor: 4.207

5.  NEMF mutations that impair ribosome-associated quality control are associated with neuromuscular disease.

Authors:  Paige B Martin; Yu Kigoshi-Tansho; Roger B Sher; Gianina Ravenscroft; Jennifer E Stauffer; Rajesh Kumar; Ryo Yonashiro; Tina Müller; Christopher Griffith; William Allen; Davut Pehlivan; Tamar Harel; Martin Zenker; Denise Howting; Denny Schanze; Eissa A Faqeih; Naif A M Almontashiri; Reza Maroofian; Henry Houlden; Neda Mazaheri; Hamid Galehdari; Ganka Douglas; Jennifer E Posey; Monique Ryan; James R Lupski; Nigel G Laing; Claudio A P Joazeiro; Gregory A Cox
Journal:  Nat Commun       Date:  2020-09-15       Impact factor: 14.919

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.